Table 3.
Characteristic | Omeprazole group (n = 303) | Pantoprazole group (n = 304) | P value |
---|---|---|---|
Target coronary vessel [n (%)] | |||
Single-vessel | 84 (29.2) | 94 (32.3) | 0.42 |
Multivessel | 206 (71.5) | 197 (67.7) | 0.32 |
Localization of culprit lesion [n (%)] | |||
Left main coronary artery | 40 (13.2) | 38 (12.5) | 0.81 |
Left anterior descending artery | 219 (72.3) | 225 (74.0) | 0.65 |
Left circumflex artery | 142 (46.9) | 135 (44.4) | 0.57 |
Right coronary artery | 164 (54.1) | 158 (52.0) | 0.63 |
Other artery | 113 (37.3) | 91 (29.9) | 0.06 |
Baseline blood flow in the culprit vessel [n (%)] | |||
TIMI 0 | 47 (15.7) | 35 (11.6) | 0.16 |
TIMI 1 | 18 (6.0) | 17 (5.6) | 0.86 |
TIMI 2 | 33 (11.0) | 27 (8.9) | 0.42 |
TIMI 3 | 202 (67.3) | 223 (73.8) | 0.09 |
Final blood flow in the culprit vessel [n (%)] | |||
TIMI 0 | 8 (2.7) | 11 (3.6) | 0.64 |
TIMI 3 | 281 (93.7) | 285 (94.4) | 0.73 |
Characteristics of coronary angiography | 0.23 | ||
Number of implanted stents (n) | 1.29 ± 1.63 | 1.18 ± 1.07 | 0.23 |
Average stent diameter (mm) | 2.24 ± 1.42 | 2.22 ± 1.44 | 0.81 |
Average length of implanted stents (mm) | 18.62 ± 12.50 | 18.55 ± 12.98 | 0.94 |
Contrast media [n (%)] | |||
Isotonic | 25 (8.4) | 27 (9.0) | 0.85 |
Non-isotonic | 274 (91.6) | 273 (91.0) | 0.85 |
Median contrast agent dose (ml) | 220.20 ± 134.97 | 205.73 ± 118.83 | 0.16 |